Skip to content

Topical Treatment of Phimosis

Topical Treatment of Phimosis: Identifying Success Factors

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-76bhgyb
Enrollment
Unknown
Registered
2022-09-12
Start date
2017-01-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Phimosis

Interventions

A randomized, double-blind clinical trial will be conducted in children diagnosed with phimosis. The study will be carried out at the pediatric outpatient clinic of Hospital Maternity Therezinha de Je
D08.811.277.450.529

Sponsors

Faculdade de Ciências Médicas e da Saúde de Juiz de Fora
Lead Sponsor
Faculdade de Ciências Médicas e da Saúde de Juiz de Fora
Collaborator

Eligibility

Sex/Gender
Male
Age
3 Years to 10 Years

Inclusion criteria

Inclusion criteria: Children from 3 to 10 years old; phimosis diagnosis

Exclusion criteria

Exclusion criteria: History of recent treatment with corticosteroids, systemic or topical, in a period of less than 6 months; inappropriate use of the prescribed medication with the presence of side effects that require treatment interruption; recurrent urinary tract infection

Design outcomes

Primary

MeasureTime frame
Total exposure of the glans in a period of 60 or 120 days, verified through the Kayaba classification, based on the findings made in the pre- and post-intervention clinical examination

Secondary

MeasureTime frame
Secondary outcomes are not expected

Countries

Brazil

Contacts

Public ContactRosa Maria Santos

Faculdade de Ciências Médicas e da Saúde de Juiz de Fora

rosa.santos@suprema.edu.br+55-032-988997604

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Feb 6, 2026